Glenview Trust’s Sanofi SNY Stock Holding History

Glenview Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,303	Closed	-$262K	–	423
2021 Q1	$262K	Buy	+5,303	New	+$255K	0.01%	359

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Glenview Trust's SNY Position: Q2 2021 in Review

Glenview Trust sold out of Sanofi (SNY) in Q2 2021, closing a stake of 5,303 shares — an estimated $262K sold.

Glenview Trust first reported a position in SNY in Q1 2021 and held it in 1 quarter. The position peaked at $262K in Q1 2021. 585 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

Glenview Trust reported no remaining Sanofi position as of Q2 2021 after selling out during the quarter.
Glenview Trust sold 5,303 Sanofi shares in Q2 2021, an estimated $262K.
Glenview Trust first reported a position in Sanofi in Q1 2021 and held it in 1 quarter.
Glenview Trust's Sanofi position peaked at $262K in Q1 2021.
585 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on Glenview Trust's 13F filing for Q2 2021, filed 11 Aug 2021.